The $3.7 million, three-year grant will go toward research aimed to develop imaging technology that allows the recording of tens of thousands of neurons to better understand how the brain goes awry in disease.
$5.1 million grant will fund research to develop stem cell-based therapy for blinding eye conditions
The award by the California Institute for Regenerative Medicine brings hope to those dealing with untreatable blindness such as macular degeneration.
Arcadia, a charitable fund of Lisbet Rausing and Peter Baldwin, gives $5.5 million to support Documenting Global Voices.
Researchers from the School of Dentistry and the David Geffen School of Medicine will use a technology created in the lab of Dr. David Wong from the dental school.
The state-funded IMPACT program provides access to free treatment for uninsured and underinsured men in California.
The awards are part of an L.A. Care initiative intended to recruit more physicians to serve Los Angeles County’s most vulnerable residents.
The Synthetic Control Across Length-scales for Advancing Rechargeables center will help accelerate research on new types of chemistry and materials that can help improve batteries’ capacity, stability and safety.
The new work will continue a study that began in 2013 with a $7 million grant from the National Institute on Drug Abuse.
An earlier $2 million grant from the foundation established the California Policy Lab in 2017.
The award from the Patient-Centered Outcomes Research Institute will be used to compare care delivered through a health system with care that occurs in a community-based setting.
The five-year award is intended to fund a research project that addresses the needs of both patients and caregivers.
The five-year project funded by the National Institute of Allergy and Infectious Diseases will involve three projects to investigate factors that accelerate and prevent the re-emergence of HIV.
The five-year award will support work to identify the “missing pieces of the puzzle” behind the disorder.
Ten years after it was introduced, vaccination rates among U.S. adolescents remain low. Research led by Roshan Bastani will examine strategies for getting more adolescents to receive the vaccine.
The grants totaling more than $10 million highlight innovative biomedical research projects.
The grant “will allow UCLA to continue our decade-long preeminence in groundbreaking autism research,” said Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment.
The grant will enable scholars to pursue new research, develop state-of-the-art digital resources and forge international collaborations.
The National Institute of Drug Abuse grant will go toward developing a resource and data center for use among researchers across the U.S. and Canada.
UCLA researchers intend to develop devices to help patients easily conduct their own health screenings and help doctors be aware of their patients’ long-term risks.
Scientists will use the funds in part to develop medications to prevent organ rejection after surgery.
Team led by UCLA, UCSF receives $8 million to study virus that often strikes after kidney transplants
The group’s research will aim to identify new strategies for combating cytomegalovirus, a frequent cause of organ rejection.
Researchers from seven institutions are studying the well-being of adolescents and young adults with the virus or at risk for infection.
The researchers will identify biomarkers associated with the development of epilepsy and develop therapies designed to prevent or modify the condition.
Researchers believe that modulating electrical signals in the autonomic nervous system holds promise for better ways to treat heart failure and other common cardiovascular problems.
Joan Asarnow is working on a pair of projects aimed at combating rising suicide rates among young people and changing prevention and care throughout the U.S.